-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Nexcella Announces Additional Positive NXC-201 Clinical Data

Reuters · 01/06/2023 08:15
BRIEF-Nexcella Announces Additional Positive NXC-201 Clinical Data

- Immix Biopharma Inc IMMX.O:

  • IMMIX BIOPHARMA SUBSIDIARY NEXCELLA, INC. ANNOUNCES ADDITIONAL POSITIVE NXC-201 CLINICAL DATA DEMONSTRATING 100% COMPLETE RESPONSES IN RELAPSED/REFRACTORY AL AMYLOIDOSIS PATIENTS, DURATION OF RESPONSE NOT YET REACHED

Source text for Eikon: ID:

Further company coverage: IMMX.O


((Reuters.Briefs@thomsonreuters.com;))